Claude Labrie - Publications

Affiliations: 
Universite Laval (Canada) 
Area:
Molecular Biology, Oncology, Cell Biology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Côté I, Lavoie L, Beauregard A, ... Labrie C, et al. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 81: 46-56. PMID 25771041 DOI: 10.1016/j.maturitas.2015.02.005  0.96
2015 Archer DF, Labrie F, Bouchard C, Portman DJ, Koltun W, Cusan L, Labrie C, Côté I, Lavoie L, Martel C, Balser J. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause (New York, N.Y.). PMID 25734980 DOI: 10.1097/GME.0000000000000428  0.96
2015 Bouchard C, Labrie F, Archer DF, Portman DJ, Koltun W, Elfassi É, Grainger DA, Ayotte N, Cooper TA, Martens M, Waldbaum AS, Labrie C, Côté I, Lavoie L, Martel C, et al. Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric : the Journal of the International Menopause Society. 18: 590-607. PMID 25511551 DOI: 10.3109/13697137.2014.992012  0.96
2014 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Gilbert L, et al. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. The Journal of Sexual Medicine. 11: 1766-85. PMID 24774442 DOI: 10.1111/jsm.12517  0.96
2014 Choi J, Djebbar S, Fournier A, Labrie C. The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by endoplasmic reticulum stress. Cell Stress & Chaperones. 19: 439-46. PMID 24122553 DOI: 10.1007/s12192-013-0471-6  0.96
2013 Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. The Journal of Steroid Biochemistry and Molecular Biology. 138: 359-67. PMID 23954500 DOI: 10.1016/j.jsbmb.2013.08.002  0.36
2011 Labrie F, Archer DF, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, et al. Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric : the Journal of the International Menopause Society. 14: 282-8. PMID 21244215 DOI: 10.3109/13697137.2010.535226  0.36
2010 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, et al. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 26: 524-32. PMID 20459349 DOI: 10.3109/09513590903511547  0.36
2009 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Bérubé R, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause (New York, N.Y.). 16: 897-906. PMID 19436226 DOI: 10.1097/gme.0b013e31819e8930  0.36
2009 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause (New York, N.Y.). 16: 907-22. PMID 19436225 DOI: 10.1097/gme.0b013e31819e8e2d  0.36
2009 Léveillé N, Fournier A, Labrie C. Androgens down-regulate myosin light chain kinase in human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 114: 174-9. PMID 19429448 DOI: 10.1016/j.jsbmb.2009.02.002  0.36
2009 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, et al. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause (New York, N.Y.). 16: 923-31. PMID 19424093 DOI: 10.1097/gme.0b013e31819e85c6  0.36
2009 Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause (New York, N.Y.). 16: 30-6. PMID 18820592 DOI: 10.1097/gme.0b013e31817b6132  0.36
2008 Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology. 111: 178-94. PMID 18598765 DOI: 10.1016/j.jsbmb.2008.06.003  0.36
2008 Labrie C, Lessard J, Ben Aicha S, Savard MP, Pelletier M, Fournier A, Lavergne E, Calvo E. Androgen-regulated transcription factor AIbZIP in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 108: 237-44. PMID 17933519 DOI: 10.1016/j.jsbmb.2007.09.008  0.36
2007 Ben Aicha S, Lessard J, Pelletier M, Fournier A, Calvo E, Labrie C. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells. Physiological Genomics. 31: 295-305. PMID 17712038 DOI: 10.1152/physiolgenomics.00097.2007  0.36
2007 Lessard J, Aicha SB, Fournier A, Calvo E, Lavergne E, Pelletier M, Labrie C. Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format. The Prostate. 67: 808-19. PMID 17373718 DOI: 10.1002/pros.20559  0.36
2007 Levesque MH, El-Alfy M, Berger L, Labrie F, Labrie C. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases. Urology. 69: 196-201. PMID 17270658 DOI: 10.1016/j.urology.2006.11.001  0.36
2006 Labrie F, Luu-The V, Martel C, Chernomoretz A, Calvo E, Morissette J, Labrie C. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG). The Journal of Steroid Biochemistry and Molecular Biology. 100: 52-8. PMID 16797178 DOI: 10.1016/j.jsbmb.2006.03.006  0.96
2005 Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C. Is dehydroepiandrosterone a hormone? The Journal of Endocrinology. 187: 169-96. PMID 16293766 DOI: 10.1677/joe.1.06264  0.36
2005 Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B. Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocrine Reviews. 26: 361-79. PMID 15867098 DOI: 10.1210/er.2004-0017  0.36
2005 Labrie F, Luu-The V, Calvo E, Martel C, Cloutier J, Gauthier S, Belleau P, Morissette J, Lévesque MH, Labrie C. Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid. The Journal of Endocrinology. 184: 427-33. PMID 15684350 DOI: 10.1677/joe.1.05997  0.96
2004 Labrie F, Cusan L, Gomez J, Luu-The V, Candas B, Bélanger A, Labrie C. Major impact of hormonal therapy in localized prostate cancer--death can already be an exception. The Journal of Steroid Biochemistry and Molecular Biology. 92: 327-44. PMID 15698538 DOI: 10.1016/j.jsbmb.2004.10.011  0.36
2004 Bolduc C, Larose M, Yoshioka M, Ye P, Belleau P, Labrie C, Morissette J, Raymond V, Labrie F, St-Amand J. Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. Journal of Molecular Endocrinology. 33: 429-44. PMID 15525599 DOI: 10.1677/jme.1.01503  0.96
2004 Bolduc C, Larose M, Lafond N, Yoshioka M, Rodrigue MA, Morissette J, Labrie C, Raymond V, St-Amand J. Adipose tissue transcriptome by serial analysis of gene expression. Obesity Research. 12: 750-7. PMID 15166294 DOI: 10.1038/oby.2004.90  0.96
2004 Larose M, St-Amand J, Yoshioka M, Belleau P, Morissette J, Labrie C, Raymond V, Labrie F. Transcriptome of mouse uterus by serial analysis of gene expression (SAGE): comparison with skeletal muscle. Molecular Reproduction and Development. 68: 142-8. PMID 15095334 DOI: 10.1002/mrd.20065  0.96
2004 Leblanc M, Bélanger MC, Julien P, Tchernof A, Labrie C, Bélanger A, Labrie F. Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions. The Journal of Clinical Endocrinology and Metabolism. 89: 1849-57. PMID 15070955 DOI: 10.1210/jc.2003-031233  0.36
2004 Labrie F, Champagne P, Labrie C, Roy J, Laverdière J, Provencher L, Potvin M, Drolet Y, Pollak M, Panasci L, L'Espérance B, Dufresne J, Latreille J, Robert J, Samson B, et al. Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer Journal of Clinical Oncology. 22: 864-871. PMID 14990642 DOI: 10.1200/JCO.2004.05.122  0.96
2003 Qi H, Grenier J, Fournier A, Labrie C. Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Molecular and Cellular Endocrinology. 210: 51-62. PMID 14615060  0.36
2003 Labrie F, Cusan L, Gomez JL, Candas B, Bélanger A, Luu-The V, Labrie C, Simard J. [From the gene to the clinic: prostate cancer death can now be an exception?]. MéDecine Sciences : M/S. 19: 910-9. PMID 14612999 DOI: 10.1051/medsci/20031910910  0.36
2003 Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey. The Journal of Clinical Endocrinology and Metabolism. 88: 4293-302. PMID 12970301 DOI: 10.1210/jc.2003-022012  0.36
2003 Labrie F, El-Alfy M, Berger L, Labrie C, Martel C, Bélanger A, Candas B, Pelletier G. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health? Endocrinology. 144: 4700-6. PMID 12960051 DOI: 10.1210/en.2003-0269  0.36
2003 Labrie F, Luu-The V, Labrie C, Bélanger A, Simard J, Lin SX, Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Reviews. 24: 152-82. PMID 12700178 DOI: 10.1210/er.2001-0031  0.36
2003 Qi H, Fournier A, Grenier J, Fillion C, Labrie Y, Labrie C. Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of C-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells. Endocrinology. 144: 1742-52. PMID 12697679 DOI: 10.1210/en.2002-220984  0.52
2003 Pouliot F, Blais A, Labrie C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Research. 63: 277-81. PMID 12543773  0.96
2003 Gutman M, Couillard S, Labrie F, Candas B, Labrie C. Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice. International Journal of Cancer. 103: 268-76. PMID 12455043 DOI: 10.1002/ijc.10803  0.36
2002 Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey. The Journal of Steroid Biochemistry and Molecular Biology. 81: 159-64. PMID 12137806 DOI: 10.1016/S0960-0760(02)00059-6  0.36
2002 Blais A, Monté D, Pouliot F, Labrie C. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. The Journal of Biological Chemistry. 277: 31679-93. PMID 12077144 DOI: 10.1074/jbc.M204554200  1
2002 Gutman M, Couillard S, Roy J, Labrie F, Candas B, Labrie C. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice. International Journal of Cancer. 99: 273-8. PMID 11979444 DOI: 10.1002/ijc.10302  0.36
2002 Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer Research. 62: 721-33. PMID 11830526  0.52
2002 Pouliot F, Labrie C. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. The Journal of Endocrinology. 172: 187-98. PMID 11786386  1
2001 Lapointe J, Labrie C. Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation. Endocrinology. 142: 4331-4338. PMID 28204441 DOI: 10.1210/endo.142.10.8417  0.96
2001 Lapointe J, Labrie C. Role of the cyclin-dependent kinase inhibitor p27kip1 in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation Endocrinology. 142: 4331-4338. PMID 11564693 DOI: 10.1210/en.142.10.4331  0.96
2001 Qi H, Labrie Y, Grenier J, Fournier A, Fillion C, Labrie C. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Molecular and Cellular Endocrinology. 182: 181-92. PMID 11514053  0.52
2001 Barbier O, Albert C, Martineau I, Vallée M, High K, Labrie F, Hum DW, Labrie C, Bélanger A. Glucuronidation of the nonsteroidal antiestrogen EM-652 (SCH 57068), by human and monkey steroid conjugating UDP-glucuronosyltransferase enzymes. Molecular Pharmacology. 59: 636-45. PMID 11179460 DOI: 10.1124/mol.59.3.636  0.36
2000 Picard F, Deshaies Y, Lalonde J, Samson P, Labrie C, Bélanger A, Labrie F, Richard D. Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats International Journal of Obesity. 24: 830-840. PMID 10918529 DOI: 10.1038/sj.ijo.0801240  0.96
2000 Pelletier C, Labrie C, Labrie F. Localization of oestrogen receptor α, oestrogen receptor β and androgen receptors in the rat reproductive organs Journal of Endocrinology. 165: 359-370. PMID 10810300 DOI: 10.1677/JOE.0.1650359  0.96
2000 Couillard S, Labrie C, Gauthier S, Merand Y, Singh SM, Candas B, Labrie F. Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice. International Journal of Cancer. 85: 424-9. PMID 10652436 DOI: 10.1002/(SICI)1097-0215(20000201)85:3<424::AID-IJC20>3.0.CO;2-S  0.36
1999 Lapointe J, Fournier AA, Richard V, Labrie C. Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells* * This work was supported by a grant from the Canadian Breast Cancer Research Initiative (to C.L.), scholarships from the Fonds de la Recherche en Santé du Québec (to C.L. and J.L.). Additional financial support was provided by Endorecherche. Endocrinology. 140: 416-421. PMID 28200729 DOI: 10.1210/endo.140.1.6410  0.96
1999 Lapointe J, Labrie C. Identification and Cloning of a Novel Androgen-Responsive Gene, Uridine Diphosphoglucose Dehydrogenase, in Human Breast Cancer Cells1. Endocrinology. 140: 4486-4493. PMID 28200594 DOI: 10.1210/endo.140.10.7071  0.96
1999 Gutman M, Couillard S, Labrie F, Candas B, Labrie C. Effects of the antiestrogen EM-800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR-75-1 breast cancer xenografts in nude mice. Cancer Research. 59: 5176-80. PMID 10537294  0.36
1999 Couillard S, Gutman M, Labrie F, Candas B, Labrie C. Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice. Cancer Research. 59: 4857-63. PMID 10519396  0.36
1999 Pouliot F, Labrie C. Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. International Journal of Cancer. 81: 98-103. PMID 10077159 DOI: 10.1002/(SICI)1097-0215(19990331)81:1<98::AID-IJC17>3.0.CO;2-9  1
1998 Martel CL, Labrie C, Be Langer A, Gauthier S, Me Rand Y, Li X, Provencher L, Candas B, Labrie F. Comparison of the Effects of the New Orally Active Antiestrogen EM-800 with ICI 182 780 and Toremifene on Estrogen-Sensitive Parameters in the Ovariectomized Mouse. Endocrinology. 139: 2486-2492. PMID 28200575 DOI: 10.1210/endo.139.5.5968  0.36
1998 Tremblay A, Tremblay GB, Labrie C, Labrie F, Gigue Re V. EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors α and β. Endocrinology. 139: 111-118. PMID 28200444 DOI: 10.1210/endo.139.1.5702  0.36
1998 Sourla A, Martel CL, Labrie C, Labrie F. Almost Exclusive Androgenic Action of Dehydroepiandrosterone in the Rat Mammary Gland. Endocrinology. 139: 753-764. PMID 28200342 DOI: 10.1210/endo.139.2.5762  0.36
1998 Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochemical and Biophysical Research Communications. 247: 146-53. PMID 9636670 DOI: 10.1006/bbrc.1998.8497  1
1998 Couillard S, Labrie C, Bélanger A, Candas B, Pouliot F, Labrie F. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts. Journal of the National Cancer Institute. 90: 772-8. PMID 9605648 DOI: 10.1093/jnci/90.10.772  1
1998 Sourla A, Martel C, Labrie C, Labrie F. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland Endocrinology. 139: 753-764. PMID 9449650 DOI: 10.1210/en.139.2.753  0.96
1998 Couillard S, Gutman M, Labrie C, Bélanger A, Candas B, Labrie F. Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice. Cancer Research. 58: 60-4. PMID 9426058  0.36
1997 Luo S, Sourla A, Labrie C, Be Langer A, Labrie F. Combined Effects of Dehydroepiandrosterone and EM-800 on Bone Mass, Serum Lipids, and the Development of Dimethylbenz(A)Anthracene-Induced Mammary Carcinoma in the Rat. Endocrinology. 138: 4435-4444. PMID 28200224 DOI: 10.1210/endo.138.10.5429  0.36
1997 Sourla A, Luo S, Labrie C, Be Langer A, Labrie F. Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800. Endocrinology. 138: 5605-5617. PMID 28200117 DOI: 10.1210/endo.138.12.5560  0.36
1997 Luo S, Labrie C, Be Langer A, Labrie F. Effect of Dehydroepiandrosterone on Bone Mass, Serum Lipids, and Dimethylbenz(a)anthracene-Induced Mammary Carcinoma in the Rat. Endocrinology. 138: 3387-3394. PMID 28199601 DOI: 10.1210/endo.138.8.5345  0.36
1997 Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, Mérand Y, Bélanger A, Labrie C, et al. (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen. Journal of Medicinal Chemistry. 40: 2117-22. PMID 9216828 DOI: 10.1021/jm970095o  0.36
1996 Poirier D, Mérand Y, Labrie C, Labrie F. D-ring alkylamide derivatives of estradiol: Effect on ER-binding affinity and antiestrogenic activity Bioorganic and Medicinal Chemistry Letters. 6: 2537-2542. DOI: 10.1016/0960-894X(96)00472-6  0.96
1995 Labrie Y, Durocher F, Lachance Y, Turgeon C, Simard J, Labrie C, Labrie F. The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. Dna and Cell Biology. 14: 849-61. PMID 7546291 DOI: 10.1089/DNA.1995.14.849  0.52
1991 Levesque C, Merand Y, Dufour JM, Labrie C, Labrie F. Synthesis and biological activity of new halo-steroidal antiestrogens. Journal of Medicinal Chemistry. 34: 1624-30. PMID 2033587 DOI: 10.1021/JM00109A014  0.36
1990 Poirier D, Labrie C, Mérand Y, Labrie F. Derivatives of ethynylestradiol with oxygenated 17α-alkyl side chain: Synthesis and biological activity Journal of Steroid Biochemistry. 36: 133-142. PMID 2362442 DOI: 10.1016/0022-4731(90)90123-A  0.96
1989 Luu The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Bérubé D, Gagné R. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta. Molecular Endocrinology (Baltimore, Md.). 3: 1301-9. PMID 2779584 DOI: 10.1210/mend-3-8-1301  0.52
1989 Labrie F, Luu-The V, Labrie C, Bérubé D, Couet J, Zhao HF, Gagné R, Simard J. Characterization of two mRNA species encoding human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17. Journal of Steroid Biochemistry. 34: 189-97. PMID 2483219 DOI: 10.1016/0022-4731(89)90082-4  0.36
1988 Pelletier G, Labrie C, Simard J, Duval M, Martinoli MG, Zhao H, Labrie F. Effects of sex steroids on regulation of the levels of C1 peptide of rat prostatic steroid-binding protein mRNA evaluated by in-situ hybridization Journal of Molecular Endocrinology. 1: 213-223. PMID 2475128 DOI: 10.1677/JME.0.0010213  0.96
1988 Simard J, Labrie C, Hubert JF, Labrie F. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland. Molecular Endocrinology (Baltimore, Md.). 2: 775-84. PMID 2459604 DOI: 10.1210/mend-2-9-775  0.36
1987 Labrie F, Dupont A, Bélanger A, Cusan L, Giguère M, Lacourcière Y, Luthy I, Bégin D, Labrie C, Simard J. Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience. Cancer Metastasis Reviews. 6: 615-36. PMID 3327635 DOI: 10.1007/BF00047470  0.36
1987 Labrie C, Cusan L, Plante M, Lapointe S, Labrie F. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer Journal of Steroid Biochemistry. 28: 379-384. PMID 2444770 DOI: 10.1016/0022-4731(87)91054-5  0.96
Show low-probability matches.